Invention Grant
US07973040B2 Macrocyclic quinoxaline compounds as HCV NS3 protease inhibitors
有权
大环喹喔啉化合物作为HCV NS3蛋白酶抑制剂
- Patent Title: Macrocyclic quinoxaline compounds as HCV NS3 protease inhibitors
- Patent Title (中): 大环喹喔啉化合物作为HCV NS3蛋白酶抑制剂
-
Application No.: US12504955Application Date: 2009-07-17
-
Publication No.: US07973040B2Publication Date: 2011-07-05
- Inventor: Steven Harper , Vincenzo Summa , Nigel J. Liverton , John A. McCauley
- Applicant: Steven Harper , Vincenzo Summa , Nigel J. Liverton , John A. McCauley
- Applicant Address: US NJ Rahway IT Rome
- Assignee: Merck Sharp & Dohme Corp.,Istituto di Ricerche di Biologia Molecolare P. Angeletti SpA
- Current Assignee: Merck Sharp & Dohme Corp.,Istituto di Ricerche di Biologia Molecolare P. Angeletti SpA
- Current Assignee Address: US NJ Rahway IT Rome
- Agent Julie M. Lake; Sheldon O. Heber
- Main IPC: C07D498/08
- IPC: C07D498/08 ; A61K31/40 ; A61P31/22
Abstract:
The present invention relates to macrocyclic a compound of formula (I) and its use as inhibitors of the hepatitis C virus (HCV) NS3 protease, and in treating or preventing HCV infections.
Public/Granted literature
- US20100029666A1 Macrocyclic Quinoxaline Compounds as HCV NS3 Protease Inhibitors Public/Granted day:2010-02-04
Information query
